Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLG | P00747 | 3/20 | 0.71 |
| ▸ | KLK1 | P06870 | 2/20 | 0.71 |
| ▸ | KLK6 | Q92876 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.68 |
| ▸ | MEN1 | O00255 | 5/20 | 0.68 |
| ▸ | POLB | P06746 | 5/20 | 0.68 |
| ▸ | NPC1 | O15118 | 4/20 | 0.68 |
| ▸ | RAB9A | P51151 | 4/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.68 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.68 |
| ▸ | CASP3 | P42574 | 1/20 | 0.65 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.65 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.65 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.64 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.64 |
| ▸ | PLAU | P00749 | 2/20 | 0.58 |
| ▸ | F2 | P00734 | 1/20 | 0.56 |
| ▸ | F10 | P00742 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11037380 | 0.92 | PLG (0.68) | PLGKLK1KLK6KMT2AMEN1 | |
| SCHEMBL11307013 | 0.92 | PLG (0.79) | PLGKLK1KLK6KMT2AMEN1 | |
| SCHEMBL2743099 | 0.89 | KMT2A (0.79) | PLGKLK1KLK6KMT2AMEN1 | |
| SCHEMBL5426499 | 0.85 | KMT2A (0.84) | PLGKLK1KLK6KMT2AMEN1 | |
| SCHEMBL13593315 | 0.85 | PLG (0.70) | PLGKLK1KLK6KMT2AMEN1 | |
| SCHEMBL14328955 | 0.85 | PLG (0.77) | PLGKLK1KLK6KMT2AMEN1 | |
| SCHEMBL21274131 | 0.83 | PLG (1.00) | PLGKLK1KLK6KMT2AMEN1 | |
| SCHEMBL13593311 | 0.83 | PLG (0.67) | PLGKLK1KLK6KMT2AMEN1 | |
| Hydrochloric Acid SCHEMBL22799474 | 0.82 | PLG (1.00) | PLGKLK1KLK6KMT2AMEN1 | |
| SCHEMBL2743097 | 0.81 | KMT2A (1.00) | PLGKLK1KLK6KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7897309-B2 | Bisazo compound, 2-hydroxy-3-phenylcarbamoyl naphthalene compound and method manufacturing bisazo compound | RICOH COMPANY, LTD. (JP) | 2011-03-01 | — | — | US | disclosed |
| US-20080096117-A1 | Bisazo compound, 2-hydroxy-3-phenylcarbamoyl naphthalene compound and method manufacturing bisazo compound | RICOH COMPANY, LTD. | 2008-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080096117-A1 | Bisazo compound, 2-hydroxy-3-phenylcarbamoyl naphthalene compound and method manufacturing bisazo compound | AHR, PBRM1, AR | PLG 4476/4885KLK1 3032/4885KLK6 4126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.